cno-20200917
0001224608falsetrue00012246082020-09-172020-09-170001224608us-gaap:CommonStockMember2020-09-172020-09-170001224608cno:RightsToPurchaseSeriesDJuniorParticipatingPreferredStockMember2020-09-172020-09-17


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 17, 2020

CNO Financial Group, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware001-3179275-3108137
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)(I.R.S. Employer
Identification No.)
11825 North Pennsylvania Street
Carmel, Indiana  46032
(Address of Principal Executive Offices) (Zip Code)

(317) 817-6100
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value 00012246082020-09-172020-09-170001224608us-gaap:CommonStockMember2020-09-172020-09-170001224608cno:RightsToPurchaseSeriesDJuniorParticipatingPreferredStockMember2020-09-172020-09-17


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 17, 2020

CNO Financial Group, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware001-3179275-3108137
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)(I.R.S. Employer
Identification No.)
11825 North Pennsylvania Street
Carmel, Indiana  46032
(Address of Principal Executive Offices) (Zip Code)

(317) 817-6100
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, par value $0.01 per shareCNONew York Stock Exchange
Rights to purchase Series D Junior Participating Preferred StockNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 7.01.Regulation FD Disclosure.

On September 17, 2020, CNO Financial Group, Inc. (the "Company") issued an Investor Overview presentation.  This presentation and future updates to this presentation will be posted in the Investors section of the Company's website: ir.CNOinc.com. A copy of this information is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01(d).Financial Statements and Exhibits.

The following material is furnished as an exhibit to this Current Report on Form 8-K:





2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CNO Financial Group, Inc.
Date: September 17, 2020
By:/s/ John R. Kline
John R. Kline
Senior Vice President and
Chief Accounting Officer




CNONew York Stock Exchange
Rights to purchase Series D Junior Participating Preferred StockNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 7.01.Regulation FD Disclosure.

On September 17, 2020, CNO Financial Group, Inc. (the "Company") issued an Investor Overview presentation.  This presentation and future updates to this presentation will be posted in the Investors section of the Company's website: ir.CNOinc.com. A copy of this information is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information contained in this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01(d).Financial Statements and Exhibits.

The following material is furnished as an exhibit to this Current Report on Form 8-K:
99.1





2




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CNO Financial Group, Inc.
Date: September 17, 2020
By:/s/ John R. Kline
John R. Kline
Senior Vice President and
Chief Accounting Officer




3
exhibit99109172020
Exhibit 99.1 Investor Overview September 2020


 
Important Legal Information Forward-Looking Statements Certain statements made in this presentation should be considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These include statements about future results of operations and capital plans. We caution investors that these forward-looking statements are not guarantees of future performance, and actual results may differ materially. Investors should consider the important risks and uncertainties that may cause actual results to differ, including those included in our Quarterly Reports on Form 10-Q, our Annual Report on Form 10-K and other filings we make with the Securities and Exchange Commission. We assume no obligation to update this presentation, which speaks as of today’s date. Non-GAAP Measures This presentation contains financial measures that differ from the comparable measures under Generally Accepted Accounting Principles (GAAP). Reconciliations between those non-GAAP measures and the comparable GAAP measures are included in the Appendix, or on the page such measure is presented. While management believes the measures are useful to enhance understanding and comparability of our financial results, these non-GAAP measures should not be considered substitutes for the most directly comparable GAAP measures. Additional information concerning non-GAAP measures is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – SEC Filings” section of CNO’s website, CNOinc.com. CNO Financial Group | Investor Overview | September 2020 2


 
CNO Financial Group Overview Focused on serving the protection needs of the fast-growing but underserved middle-income American market at or near retirement . Manufactured products include life, fixed annuities, Medicare supplement, supplemental health and limited benefit duration long-term care (LTC) . Distribution of third party Medicare Advantage . Demonstrated growth in agents, premiums, assets and third party fees Average Liabilities by Insurance Total: $1.8B in Total Collected Premiums YTD 2Q20 Product YTD 2Q20* Interest sensitive life YTD 2Q20 Collected YTD 2Q20 Insurance 5% Premium by Product Margin by Product Medicare Traditional supplement life 1% 10% Fixed index Life Life Supplemental annuities 18% 39% 23% Med Supp Supp health Health 16% Health 21% Supp Health 19% Med Supp 47% Health Annuities 41% 19% 16% Annuities LTC 41% LTC 30% 7% 6% Long-term care 14% Fixed interest Other annuities annuities 3% 12% *Net of reinsurance ceded CNO Financial Group | Investor Overview | September 2020 3


 
What Makes CNO Different Exclusive Focus on Middle- Our Diverse Distribution & Income America Integrated Approach Insurance and Securities Health and Wealth Solutions Solutions Strong Cash Flow Generation CNO Financial Group | Investor Overview | September 2020 4


 
Well-Positioned in the Attractive Senior Middle Market 63% of middle-income households are underinsured; ~60% of baby boomers lack financial advisors1 Percentage of Population Age 65+ CNO Solutions without a Financial Product CNO Solutions . Extensive experience and understanding of the middle market Other Health 84% . Differentiated with our market vs. product focus LTC 83% . Diversification of products and distribution provides sustainable Annuities 78% competitive advantage . Positioned to help customers to address main concerns of outliving Medicare Supplement 60% their assets and dealing with rising healthcare costs as they age Life Insurance 40% (1) Bankers Life Center for a Secure Retirement 2017 CNO Financial Group | Investor Overview | September 2020 5


 
Highly Diversified Product Mix Broad & balanced portfolio focused on protection needs Product Offering Key Points . Basic products that meet the insurance 1 Life Insurance needs of the middle-market . Attractive and predictable return 2 Annuities characteristics . Mix of protection and accumulation 3 Medicare products to serve varied customer needs . Product mix balances interest rate risk 4 Supplemental Health with shorter duration pure mortality and morbidity insurance . Lower risk long-term care products with 5 Long-Term Care short-duration benefit period CNO Financial Group | Investor Overview | September 2020 6


 
Risk Management via Diversification and Natural Hedges Relative degree of risk present (before mitigation) within each product Fixed Fixed Interest Trad Med Supp Indexed Interest Sensitive LTC Life Supp Health Annuity Annuity Life Mortality Morbidity Persistency Interest rate Equity Low High CNO Financial Group | Investor Overview | September 2020 7


 
Unique Multi-Channel Operating Model Recent realignment removes barriers between brand and channels . Consumer Division – Strong career agent franchise • Top distributor of health/wealth protection products through ~4,100 producing agents • More than 265 locations nationwide • “Kitchen-table” sales model – Top 5 direct-to-consumer distribution – Broker-dealer and RIA offer investment and annuity products and support agent income . Worksite Division – Wholly-owned distribution (PMA) & diverse network of independent marketing organizations and agencies – Web Benefits Design (WBD) digital worksite enrollment platform/benefits administrator . Multi-channel distribution transitioning to integrated delivery model – Recent business transformation unlocks significant growth opportunities – Leverages products, brands, leads and fulfilment across channels – Captures customers through direct engagement that leads to an integrated omnichannel buying experience – Driving toward holistic relationships including protection & retirement planning; growth in assets & fees CNO Financial Group | Investor Overview | September 2020 8


 
Strategic Initiatives Successfully Reinvigorating Growth; Momentum Sidelined Temporarily by COVID (dollars in millions) Life NAP Health NAP Annuity Collected Premiums $200.0 $200.0 $1,500.0 $150.0 $150.0 $1,000.0 $100.0 $100.0 $500.0 $50.0 $50.0 $- $- $- 2017 2018 2019 YTD YTD 2017 2018 2019 YTD YTD 2017 2018 2019 YTD YTD 2Q19 2Q20 2Q19 2Q20 2Q19 2Q20 Consumer Division NAP Worksite Division NAP $400.0 $60.0 $50.0 $300.0 $40.0 $200.0 $30.0 $20.0 $100.0 $10.0 $- $- 2018 2019 YTD YTD 2018 2019 YTD YTD 2Q19 2Q20 2Q19 2Q20 Life Health Life Health CNO Financial Group | Investor Overview | September 2020 9


 
Capital and Liquidity Overview Conservative approach to capital structure (dollars in millions) Consolidated Risk Based Capital (“RBC”) Ratio1 393% 408% 406% 405%  Targeted consolidated RBC ratio of 375-400%  Excess due to intentional conservative positioning  RBC variability can be expected in periods of market volatility 2018 2019 1Q 2020 2Q 2020 Debt to Capital2 22.3% 23.0% 23.8% 23.6%  Target leverage of 22.5 – 25.0%  Debt covenant ceiling of 35%  Debt capacity within limit of target leverage $80.7 million 2018 2019 1Q 2020 2Q 2020 x Holding Company Liquidity $220.4 $208.0 $186.7 $168.1  Minimum targeted holding company liquidity of $150 million  Liquidity bolstered by $250 million undrawn revolver  No outstanding debt maturities until 2025 2018 2019 1Q 2020 2Q 2020 1 The ratio of the combined capital of the insurance companies to the minimum amount of capital appropriate to support the overall business operations, as determined based on the methodology developed by the National Association of Insurance Commissioners. 2 Excluding accumulated other comprehensive income (a non-GAAP measure). See the Appendix for a reconciliation to the corresponding GAAP measure. CNO Financial Group | Investor Overview | September 2020 10


 
Cash Flow Profile Strong free cash flow generation and conversion (dollars in millions) For the Quarter Trailing Twelve Months 2Q19 2Q20 2Q19 2Q20 Net Operating Income1 $ 76.4 $ 79.4 $ 289.5 $ 311.5 Holding Company Cash Flows: Dividends from Subsidiaries$ 89.9 $ 77.6 $ 281.3 $ 220.8 Management Fees 28.3 27.0 111.4 114.8 Surplus Debenture Interest 12.3 12.1 59.0 59.2 Earnings on Corporate Investments 3.7 12.5 15.3 29.1 Tax Refund - - 5.8 - Other 15.4 21.0 20.0 13.2 Holding Company Sources of Cash2 149.6 150.2 492.8 437.1 Holding Company Expenses and Other (13.2) (33.0) (83.3) (109.0) Interest Payments (21.8) (26.4) (45.3) (52.1) Excess Cash Flow to Holding Company2 114.6 90.8 364.2 276.0 Net Proceeds from New Debt 64.9 - 64.9 - Share Repurchases (59.0) (30.0) (140.4) (265.3) Dividend Payments to Stockholders (17.4) (17.4) (66.7) (66.8) Contributions to Insurance Subsidiaries - - (265.0) - Acquisition (68.8) - (68.8) - Net Change in Holding Company Cash and Investments 34.3 43.4 (111.8) (56.1) Non-Cash Changes in Investment Balances - (3.5) (0.1) - Cash and Investments, Beginning of Period 229.8 168.1 376.0 264.1 Cash and Investments, End of Period$ 264.1 $ 208.0 $ 264.1 $ 208.0 Free Cash Flow Conversion 150% 114% 126% 89% 1 A non-GAAP measure. See the Appendix for a reconciliation to the corresponding GAAP measure. 2 Cash flows exclude capital contributions to insurance subsidiaries, acquisitions, dividend payments, stock repurchases, and financing transactions. CNO Financial Group | Investor Overview | September 2020 11


 
Excess Capital Allocation Strategy Disciplined and opportunistic approach to maximize shareholder value Organic investments to sustain and grow the core businesses Capital Return as % of Market Capitalization $400.0 13.0% 15.0% $300.0 6.8% 10.0% Return capital to shareholders $200.0 4.0% 5.5% 5.0% • Increased dividend 9% in 2Q20; 8th consecutive $100.0 annual increase $- 0.0% • $30 million in share repurchases in 2Q20; $113 2017 2018 2019 YTD 2Q20 million YTD Dividends • Capacity to continue modest share repurchases Share Repurchases as conditions permit Annualized Return as % of Market Cap (1) Opportunistic transactions Since 2017, returned $850 million or • Highly selective M&A to expand productivity 39% of current market capitalization (2) offerings or enhance distribution 1 As of beginning of calendar year. 2 As of 6/30/2020. CNO Financial Group | Investor Overview | September 2020 12


 
Portfolio Composition High quality; well-positioned for current environment $26 billion of Invested Assets Highlights (Fair Value as of 6/30/2020) Mortgage • 65% of portfolio in corporate and government bonds Loans, 5.8% HY Corporates, 2.9% Non-Agency RMBS, 8.7% • 41% BBBs; consistent with March 31 CMBS, • $21.6 billion of assets with high degree of liquidity 7.9% Municipals, 9.7% • ~$12.9 billion public corporate bonds • ~$5.9 billion structured securities • ~$2.8 billion municipal, political subdivisions, Govts/Agency, ABS, 4.6% 1.6% and US and foreign government bonds IG Corporates, CLO, 1.7% • Strong credit risk profile across portfolio 50.3% Equities, 0.2% Other Invested • Underweight COVID-19 impacted sectors Assets, 1.8% Alternatives, 2.1% • 96% rated NAIC 1 / 2 • Diversified commercial and residential Policy Loans, 0.5% mortgages with low LTVs Cash, 2.2% • Significant credit enhancement in structured General Approach products • Positioned for stable performance across credit cycles • Alternative investments that avoid binary • Emphasizing quality outcomes • Lower than average allocation to most higher risk categories – all carefully calibrated • Low impairments through multiple cycles CNO Financial Group | Investor Overview | September 2020 13


 
2020 Outlook Less severe mortality impact; continued capacity to maintain modest buybacks Scenario modeling – 2020 COVID impacts Prior (May) projections Current (August) projections • Mortality • Mortality • 80k – 120k U.S. COVID deaths • 150k – 400k U.S. COVID deaths • $20M – $30M net mortality impact • $20M – $52M net mortality impact • $250k per 1,000 deaths • $130k per 1,000 deaths • Morbidity • Morbidity • Net neutral impact • Favorable in 2Q20; net neutral impact in 2H20, with potential upside, if deferred healthcare and LTC treatments become permanent • Premium deferral / Shock lapse • Premium deferral / Shock lapse • Potential for significant favorable impact • Potential for modestly positive impact given uncertainty regarding persistency given favorable persistency observed in 2Q20 Key Outputs of Modeling • Base case second half earnings down compared to prior year, driven primarily by COVID-19 mortality impacts • Expenses in total excluding significant items flat to prior year, despite accelerating investments to better position for the future • Investment income not allocated to product lines also generally flat • Adverse case free cash flow supports continued modest level of share repurchase CNO Financial Group | Investor Overview | September 2020 14


 
Delivering On Our Commitments Shifting to a tactical approach while navigating COVID environment Pivot to Optimize Long- Turnaround / COVID-19 De-risking Growth term Value Pre 2017 2017-2019 2020 2021 and Beyond • Reinsured life block (2009) • Completed Senior Leadership • Balancing cash conservation • Customer-centric business • Recapitalized company (2012) additions with investments in growth realignment • Initiated dividend (2012) • Reinsured LTC block • Conservative capital structure • Omnichannel delivery model • Sold Legacy Life Insurance Block • Achieved investment grade • Enhance growth and margin credit ratings • Defensive portfolio profile (2014) positioning • Migrated ratings upwards–within • Up-in-quality portfolio • Maximize distributable cash non-investment grade ratings repositioning • Opportunistic capital flow classes • Sustainable momentum in deployment • Accelerate pace of capital recruiting and sales • Benefiting from diverse deployment product portfolio and strong • Reduced risk and volatility retention • Leverage technology • Successfully pivoting to new sales approaches • Accelerating integration of D2C and exclusive agents • Rethinking future office footprint CNO Financial Group | Investor Overview | September 2020 15


 
Appendix 1 Strong Operational Performance • COVID-19 Response Slide 17 • Experienced Management Team Slide 18 • Agent Counts Slide 19 • Broker-Dealer/Registered Investment Advisor Slide 20 Building on Strong Track Record of Execution • Investment Portfolio Overview Slides 21-24 • New Money Summary Slide 25 • Tax Asset Summary Slide 26 • Transformative LTC Reinsurance Transaction Slide 27 • Retained LTC Insurance Slide 28 CNO Financial Group | Investor Overview | September 2020 16


 
COVID-19 Response: Committed to Key Stakeholders Embracing our obligations; rising to the challenge Supporting our Helping our Associates & Agents Customers Giving Back to Others • Committed to no COVID-19 • Call centers, claims • Committed to maintaining related layoffs in 2020 processing, other services 2020 annual budget for operating remotely corporate donations to our • Introduced agent financial philanthropic community support programs • Allowing deferral of premium partners payments of up to 90 days • Provided technology, training, • Engaged associates in virtual & other tools to support • Enhanced digital capabilities volunteering opportunities to effective working from home and servicing support local food banks and first responders • COVID-19 testing & treatment • Providing agents with tools to reimbursed at 100% support virtual sales and • Donated $300,000 to support servicing; digital applications funds for associates and • Expanded PTO policies agents impacted by COVID-19 • Continuing to provide products or other personal financial • Free LiveHealth tele-visits to protect the health and emergencies retirement needs of our • Employee Assistance customers programs offering 24/7 counseling CNO Financial Group | Investor Overview | September 2020 17


 
Experienced Management Team With a Proven Track Record 10-year average tenure; 23-year average service in the insurance sector Years in Insurance Name Title Years with CNO Age Sector Gary C. Bhojwani Chief Executive Officer 4 30 52 Paul H. McDonough Chief Financial Officer 1 18 55 Eric R. Johnson Chief Investment Officer 23 23 59 Bruce K. Baude Chief Operations and Technology Officer 8 15 56 Matthew J. Zimpfer GeneralCounsel 22 27 52 Yvonne K. Franzese Chief Human Resources Officer 2 30 62 John R. Kline Chief Accounting Officer 30 40 62 Rocco F. Tarasi Chief Marketing Officer 3 3 48 Karen J. DeToro Chief Actuary and Chief Risk Officer 1 26 49 Scott L. Goldberg President, Consumer Division 15 19 50 Michael D. Heard President, Worksite Division 7 22 54 CNO Financial Group | Investor Overview | September 2020 18


 
Agent Counts Producing agent count impacted by COVID; total agent count stable 2019 2020 % Change Consumer 2Q 3Q 4Q 1Q 2Q Q/Q Total Quarterly Average Producing Agents1,3 4,602 4,579 4,709 4,531 4,066 -12% Quarterly Average Financial Representatives2,3 595 596 596 591 602 1% Worksite Total Quarterly Average Producing Agents1,3 417 420 453 421 225 -46% 1 Producing agents are agents that have submitted at least one policy in the month. 2 Financial representatives are agents who are licensed to sell certain securities brokerage products and services. 3 Quarterly average agent and advisor counts represent the average of the last 3 months. CNO Financial Group | Investor Overview | September 2020 19


 
Broker-Dealer/Registered Investment Advisor Account values up YoY; $1.5 billion in client assets (dollars in millions) 2019 2020 2Q 3Q 4Q 1Q 2Q Net New Client Assets in Brokerage $5.1 $13.4 $17.4 $15.3 -$26.7 Brokerage and Advisory1 Advisory 33.2 29.9 45.4 65.7 38.6 Total $38.3 $43.3 $62.8 $81.0 $11.9 Client Assets in Brokerage and Brokerage $886.0 $913.7 $982.9 $842.3 $905.3 Advisory1 at end of period Advisory 417.0 449.0 532.1 516.4 618.7 Total $1,303.0 $1,362.7 $1,515.0 $1,358.7 $1,524.0 1 Client assets include cash and securities in brokerage and managed advisory accounts. Net new client assets includes total inflows of cash and securities into brokerage and managed advisory accounts less outflows. Inflows include interest and dividends and exclude changes due to market fluctuations. Bankers Life is the marketing brand of various affiliated companies of CNO Financial Group including, Bankers Life and Casualty Company, Bankers Life Securities, Inc., and Bankers Life Advisory Services, Inc. Non-affiliated insurance products are offered through Bankers Life General Agency, Inc. (dba BL General Insurance Agency, Inc., AK, AL, CA, NV, PA). Agents who are financial advisors are registered with Bankers Life Securities, Inc. Securities and variable annuity products and services are offered by Bankers Life Securities, Inc. Member FINRA/SIPC, (dba BL Securities, Inc., AL, GA, IA, IL, MI, NV, PA). Advisory products and services are offered by Bankers Life Advisory Services, Inc. SEC Registered Investment Adviser (dba BL Advisory Services, Inc., AL, GA, IA, MT, NV, PA). Home Office: 111 East Wacker Drive, Suite 1900, Chicago, IL 60601 CNO Financial Group | Investor Overview | September 2020 20


 
Investment Portfolio Overview – Sector Breakdown Underweight COVID-impacted sectors 6/30/2020 (dollars in millions) Book Market Unrealized Average Sector Value Value Gain Loss Portfolio% NAIC Over|Underweight Airlines 17.2 17.7 0.5 0.07% 1.5 Underweight Aircraft Lease Securitizations 33.9 30.2 (3.7) 0.12% 1.0 Underweight Energy 710.6 774.9 64.2 3.02% 1.9 Underweight Gaming 0.0 - - - - Underweight Hotels 36.1 36.7 0.6 0.14% 2.6 Underweight Retail ex Grocery 82.6 97.4 14.7 0.38% 1.8 Underweight Restaurants 19.1 22.6 3.5 0.09% 2.8 Underweight Whole Business Securitizations 399.5 397.1 (2.3) 1.55% 2.1 Overweight CMBS 2,003.6 2,020.7 17.1 7.89% 1.0 Overweight CNO Financial Group | Investor Overview | September 2020 21


 
Investment Portfolio Overview: CLO Debt Significant cushion against stress scenarios 6/30/2020 Ratings Composition A+ % of Rating Downgrade Watch 1.5% AA Portfolio Portfolio Index 49.6% AAA 11.3% - - AA 52.0% - 0.2% A 33.2% 100% A 36.7% - 4.2% AAA AAA-A BBB - N/A 35.8% AA+ 11.3% 2.4% A- BB - N/A 51.9% 1.8% Key Portfolio Metrics Cumulative Loss / Breakpoint Analysis AAA AA A Credit Support Portfolio 37% 25% 17% Market 37% 25% 19% WARF Portfolio 3,315 3,248 3,272 Market 3,233 3,258 3,272 Diversity Score Portfolio 79 78 82 Market 77 76 75 CDR at Break Point 54.7% 27.8% 17.2% EORP Portfolio 1.73 2.13 1.81 CDR at Base Case 4.5% 4.5% 4.5% Market 2.26 2.11 2.12 CDR at GFC 5.8% 5.8% 5.8% CNO Financial Group | Investor Overview | September 2020 22


 
Investment Portfolio Overview: Commercial Mortgage Loans Very conservatively underwritten; loss resistant 6/30/2020 Key Portfolio Facts Portfolio Geography $1.4 billion of net invested assets Mountain 10.0% South Central 32.7% 17.0% 100% 99.5% 51% 1.97x 0.5% First Rated Weighted Weighted Delinquency Mortgage CM1-2 Avg LTV¹ DSCR¹ East Pacific 23.6% 16.6% Underlying Property Type Ratings Composition Office Industrial 17.1% CM1 22.5% 77.2% Other 12.2% Apartment CM2 Retail 29.2% 22.3% 19.0% CM7 1 LTV and DSCR as of year-end 2019 operating statements. 0.5% CNO Financial Group | Investor Overview | September 2020 23


 
Investment Portfolio Overview: CMBS Very conservatively underwritten; loss resistant 6/30/2020 Key Portfolio Facts Book Market Market/ Credit Delinq. $2.0 billion of net invested assets Rating Value Value Book Support Rate Hotel% Retail% AAA 622 647 104% 38.4% 7.6% 12.4% 21.6% AA 369 374 102% 29.2% 6.9% 10.6% 17.9% 80.0% 60% 2.11x A 606 588 97% 20.0% 5.1% 14.0% 13.0% BBB 330 337 102% 12.0% 0.1% 0.8% 2.5% Rated Weighted Weighted AAA-A Avg LTV¹ DSCR¹ BB 77 74 96% 3.3% - - - 2,004 2,021 101% 25.5% 5.2% 10.2% 14.3% Underlying Property Type Ratings Composition Office AA Multifamily A 30.6% 18.4% 24.0% 30.3% Industrial Retail 8.1% 14.3% AAA BBB Mixed Use 31.0% 16.5% Hotels 12.9% BB 10.2% 3.8% 1 LTV based on appraisal at loan origination, DSCR as of year-end 2019 operating statements. CNO Financial Group | Investor Overview | September 2020 24


 
2Q20 New Money Summary Emphasis on high quality investments Second Quarter Investments HY Corporates, 5.7% Direct Investments, 0.6% Average Average Allocation $ Allocation % Yield Rating Duration Structured Securities 372 40.8% 4.34% A 4.7 Municipals 241 26.5% 3.84% AA 15.4 IG Corporates, 26.4% Structured IG Corporates 241 26.4% 4.88% BBB 9.8 Securities, 40.8% HY Corporates 52 5.7% 6.16% BB 4.4 Municipals, 26.5% Direct Investments 5 0.6% 9.49% NR - Total 911 100% 4.49% A 8.8 94% Investment Grade Allocation CNO Financial Group | Investor Overview | September 2020 25


 
Tax Asset Summary Estimated economic value of NOLs & DTAs related to tax strategy of $2.80 per share Value of NOLs and deferred tax assets Details (DTAs) related to tax strategy (dollars in millions) • Total estimated economic value of NOLs $495 and DTAs related to tax strategy of DTAs related to approximately $400 million @ 10% tax strategy discount rate ($2.80 on per share basis) $75 • Life NOLs have been fully utilized. Non- life NOLs are expected to offset 100% of non-life taxable income and 35% of the remaining life taxable income not offset Non-life NOLs $420 by life NOLs through 2023. CNO Financial Group | Investor Overview | September 2020 26


 
2018 Transformative LTC Reinsurance Transaction Divestiture of legacy LTC exposure significantly improves risk profile . In September 2018, Bankers Life entered into an Reserve Composition* agreement with Wilton Re to cede 100% of Bankers Life legacy (prior to 2003) comprehensive and nursing home long-term care reserves through Pre Transaction indemnity coinsurance – Culmination of multi-year exploration of strategic LTC alternatives 24% – Comprising 52% of CNO’s statutory long-term care Fixed Annuities reserves Life 49% – $825mm ceding commission paid to Wilton Re, 13% financed from existing capital resources Health 14% . Significant risk reduction, especially in severe stress scenarios; business ceded is the most volatile from an earnings and capital perspective . Domestic comfort trust established to hold assets backing 100% of the statutory liabilities plus an Post Transaction** additional $500mm of over-collateralization LTC . Wilton Re is a highly-rated and well-capitalized 12% counterparty Fixed Annuities . Step forward in achieving investment grade ratings 56% Life . Results in increased cash flow generation 16% Health 16% * Reserve net of reinsurance ** As of September 30, 2018 CNO Financial Group | Investor Overview | September 2020 27


 
Retained Long-Term Care Insurance Highly differentiated in-force block; prudently managed . New sales (~$25 million annually) focused on short duration products – 98% of new sales for policies with 2 years or less in benefits – Average benefit period of 11 months – New business 25% reinsured since 2008 . Reserve assumptions informed by historical experience – No morbidity improvement – No mortality improvement – Minimal future rate increases – New money rate lowered to reflect a level rate throughout the projection horizon . Favorable economic profile – Loss Recognition Testing margin reflecting a level new money rate is $207 million or ~9% of Net GAAP Liabilities – Statutory reserves ~$160 million higher than GAAP net liabilities – Total LTC is just 13% of overall CNO reserves – Potential adverse impact from severe stress scenarios is significantly reduced CNO Financial Group | Investor Overview | September 2020 28


 
Appendix 2: Financial Exhibits • Non-GAAP Financial Measures Slides 30-37 CNO Financial Group | Investor Overview | September 2020 29


 
2Q20 Significant Items The table below summarizes the financial impact of significant items on our 2Q20 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. (dollars in millions, except per-share amounts) Three months ended June 30, 2020 Excluding significant Actual results Significant items items Insurance product margin Annuity$ 123.8 $ 40.0 (1) $ 72.3 (91.5) (1) Health 82.3 - 82.3 Life 36.1 5.6 (1) 41.7 Long-term care 13.2 - 13.2 Total insurance product margin 255.4 (45.9) 209.5 Allocated expenses (128.1) - (128.1) Income from insurance products 127.3 (45.9) 81.4 Fee income 5.2 - 5.2 Investment income not allocated to product lines 8.2 - 8.2 Expenses not allocated to product lines (38.5) 23.5 (2) (15.0) Operating earnings before taxes 102.2 (22.4) 79.8 Income tax expense on operating income (22.8) 4.7 (18.1) Net operating income (3)$ 79.4 $ (17.7) $ 61.7 Net operating income per diluted share (3) $0.55$ (0.12) $ 0.43 The footnotes to the above table are on the following page. CNO Financial Group | Investor Overview | September 2020 30


 
2Q20 Significant Items (Continued from the previous page) (1) Given our expectation that interest rates will remain low for the long-term, we performed an actuarial unlocking exercise in the second quarter of 2020 to reflect our assumption that average new money rates will remain flat at 4 percent forever. This change and the related impacts to persistency assumptions had a $45.6 million unfavorable impact on pre-tax earnings. As part of the actuarial unlocking exercise, we also changed our assumptions related to the future option costs we incur in providing benefits on fixed index annuities which had a favorable impact on pre-tax earnings of $91.5 million. The impact of these changes in assumptions is summarized below (dollars in millions): Line of business Fixed index Fixed interest Interest- annuities annuities sensitive life Total Favorable (unfavorable) Impacts of an average new money rate assumption of 4 percent Insurance policy benefits $ (5.0) $ — $ (7.4) $ (12.4) Amortization (25.6) (9.4) 1.8 (33.2) Subtotal (30.6) (9.4) (5.6) (45.6) Impacts of changes in future option costs Insurance policy benefits 104.8 — — 104.8 Amortization (13.3) — — (13.3) Subtotal 91.5 — — 91.5 Impact on pre-tax income $ 60.9 $ (9.4) $ (5.6) $ 45.9 This actuarial unlocking exercise does not replace our comprehensive annual review of all assumptions for our insurance products, which we we plan to complete in the fourth quarter of this year. Additional adjustments may be identified based on the results of the comprehensive annual review. (2) We increased our liability for claims and interest pursuant to the previously disclosed Global Resolution Agreement entered into in November 2018. Pursuant to this agreement, a third-party auditor is acting on behalf of 41 states and the District of Columbia for the purpose of identifying deceased insureds and contract holders where benefits are payable pursuant to unclaimed property laws. The third-party auditor has provided information that we have processed and verified allowing us to more accurately estimate the ultimate liability pursuant to this agreement. (3) A non-GAAP measure. See pages 33 and 35 for a reconciliation to the corresponding GAAP measure. CNO Financial Group | Investor Overview | September 2020 31


 
4Q19 Significant Items The table below summarizes the financial impact of significant items on our 4Q19 net operating income. Management believes that identifying the impact of these items enhances the understanding of our operating results. (dollars in millions, except per-share amounts) Three months ended December 31, 2019 Excluding significant Actual results Significant items items Insurance product margin Annuity$ 60.5 $ 0.3 (1) $ 60.8 Health 79.0 - 79.0 Life 46.7 9.7 (1) 56.4 Long-term care 14.0 14.0 Total insurance product margin 200.2 10.0 210.2 Allocated expenses (140.6) - (140.6) Income from insurance products 59.6 10.0 69.6 Fee income 11.7 - 11.7 Investment income not allocated to product lines 26.2 - 26.2 Expenses not allocated to product lines 2.8 (20.0) (2) (17.2) Operating earnings before taxes 100.3 (10.0) 90.3 Income tax expense on operating income (21.7) 2.1 (19.6) Net operating income (3)$ 78.6 $ (7.9) $ 70.7 Net operating income per diluted share (3)$ 0.52 $ (0.05) $ 0.47 (1) Adjustments arising from our comprehensive annual actuarial review of assumptions. (2) $20.0 million of the net favorable impact from legal and regulatory matters. (3) A non-GAAP measure. See pages 33 and 35 for a reconciliation to the corresponding GAAP measure. CNO Financial Group | Investor Overview | September 2020 32


 
Quarterly Earnings (dollars in millions) 2Q19 3Q19 4Q19 1Q20 2Q20 Insurance product margin Annuity$ 57.2 $ 56.2 $ 60.5 $ 59.5 $ 123.8 Health 78.3 77.0 79.0 73.6 82.3 Life 51.7 54.6 46.7 44.3 36.1 Long-term care 11.9 12.3 14.0 13.3 13.2 Total insurance product margin 199.1 200.1 200.2 190.7 255.4 Allocated expenses (135.2) (131.3) (140.6) (136.6) (128.1) Income from insurance products 63.9 68.8 59.6 54.1 127.3 Fee income 4.4 3.0 11.7 7.8 5.2 Investment income not allocated to product lines 48.3 34.3 26.2 57.4 8.2 Expenses not allocated to product lines (19.9) (18.2) 2.8 (13.8) (38.5) Operating earnings before taxes 96.7 87.9 100.3 105.5 102.2 Income tax expense on operating income (20.3) (18.7) (21.7) (21.2) (22.8) Net operating income 76.4 69.2 78.6 84.3 79.4 Net realized investment gains (losses) from sales, impairments and change in allowance for credit losses (net of related amortization) (1.7) (2.6) 7.1 (63.7) 12.3 Net change in market value of investments recognized in earnings 6.8 4.7 (2.6) (48.4) 31.2 Fair value changes in embedded derivative liabilities (net of related amortization) (35.9) (29.3) 13.4 (66.7) (27.1) Fair value changes related to agent deferred compensation plan (11.6) (6.0) 2.5 - (13.2) Loss on extinguishment of debt (7.3) - - - - Other 0.7 (1.2) (13.3) 2.3 - Non-operating income (loss) before taxes (49.0) (34.4) 7.1 (176.5) 3.2 Income tax expense (benefit): On non-operating income (loss) (10.2) (7.2) 1.4 (37.0) 0.6 Valuation allowance for deferred tax assets and other tax items - - (193.7) (34.0) - Net non-operating income (loss) (38.8) (27.2) 199.4 (105.5) 2.6 Net income (loss)$ 37.6 $ 42.0 $ 278.0 $ (21.2) $ 82.0 *Management believes that an analysis of earnings before net realized investment gains (losses) from sales, impairments and change in allowance for credit losses, net change in market value of investments recognized in earnings, fair value changes in embedded derivative liabilities, fair value changes related to the agent deferred compensation plan, loss on extinguishment of debt, loss related to reinsurance transaction, other non-operating items, corporate interest expense and taxes (“Adjusted EBIT,” a non-GAAP financial measure) provides a clearer comparison of the operating results of the company quarter-over-quarter because it excludes: (1) net realized investment gains (losses) from sales, impairments and change in allowance for credit losses; (2) net change in market value of investments recognized in earnings; (3) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities that are unrelated to the company’s underlying fundamentals; (4) loss on extinguishment of debt; (5) fair value changes related to the agent deferred compensation plan; (6) loss related to reinsurance transaction; (7) charges in the valuation allowance for deferred tax assets and other tax items; and (8) other non-operating items consisting primarily of earnings attributable to variable interest entities. The table above provides a reconciliation of Adjusted EBIT to net income. CNO Financial Group | Investor Overview | September 2020 33


 
Information Related to Certain Non-GAAP Financial Measures The following provides additional information regarding certain non-GAAP measures used in this presentation. A non-GAAP measure is a numerical measure of a company’s performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. While management believes these measures are useful to enhance understanding and comparability of our financial results, these non-GAAP measures should not be considered as substitutes for the most directly comparable GAAP measures. Additional information concerning non-GAAP measures is included in our periodic filings with the Securities and Exchange Commission that are available in the “Investors – SEC Filings” section of CNO’s website, www.CNOinc.com. Operating earnings measures Management believes that an analysis of net income applicable to common stock before net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net change in market value of investments recognized in earnings, fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, fair value changes related to the agent deferred compensation plan, loss on extinguishment of debt, loss related to reinsurance transaction, changes in the valuation allowance for deferred tax assets and other tax items and other non-operating items consisting primarily of earnings attributable to variable interest entities (“net operating income,” a non-GAAP financial measure) is important to evaluate the financial performance of the Company and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the Company’s underlying fundamentals. CNO Financial Group | Investor Overview | September 2020 34


 
Information Related to Certain Non-GAAP Financial Measures A reconciliation of net income (loss) applicable to common stock to net operating income (and related per-share amounts) is as follows: (dollars in millions, except per-share amounts) 2Q19 3Q19 4Q19 1Q20 2Q20 Net income (loss) applicable to common stock $ 37.6 $ 42.0 $ 278.0 $ (21.2) $ 82.0 Non-operating items: Net realized investment (gains) losses from sales and impairments, net of related amortization 1.7 2.6 (7.1) 63.7 (12.3) Net change in market value of investments recognized in earnings (6.8) (4.7) 2.6 48.4 (31.2) Fair value changes in embedded derivative liabilities, net of related amortization 35.9 29.3 (13.4) 66.7 27.1 Fair value changes related to the agent deferred compensation plan 11.6 6.0 (2.5) - 13.2 Loss on extinguishment of debt 7.3 - - - - Other (0.7) 1.2 13.3 (2.3) - Non-operating (income) loss before taxes 49.0 34.4 (7.1) 176.5 (3.2) Income tax (expense) benefit On non-operating (income) loss 10.2 7.2 (1.4) 37.0 (0.6) Valuation allowance for deferred tax assets and other tax items - - 193.7 34.0 - Net non-operating (income) loss 38.8 27.2 (199.4) 105.5 (2.6) Net operating income (a non-GAAP financial measure) $ 76.4 $ 69.2 $ 78.6 $ 84.3 $ 79.4 Per diluted share: Net income (loss) $ 0.24 $ 0.27 $ 1.84 $ (0.15) $ 0.57 Net realized investment (gains) losses from sales and impairments (net of related amortization and taxes) 0.01 0.01 (0.04) 0.35 (0.07) Net change in market value of investments recognized in earnings (net of taxes) (0.04) (0.02) 0.01 0.26 (0.17) Fair value changes in embedded derivative liabilities (net of related amortization and taxes) 0.18 0.15 (0.07) 0.36 0.15 Fair value changes related to the agent deferred compensation plan (net of taxes) 0.06 0.03 (0.01) - 0.07 Loss on extinguishment of debt 0.03 - - - - Valuation allowance for deferred tax assets and other tax items - - (1.28) (0.23) - Other - 0.01 0.07 (0.01) - Net operating income (a non-GAAP financial measure) $ 0.48 $ 0.45 $ 0.52 $ 0.58 $ 0.55 CNO Financial Group | Investor Overview | September 2020 35


 
Information Related to Certain Non-GAAP Financial Measures A reconciliation of operating income and shares used to calculate basic and diluted operating earnings per share is as follows: (dollars in millions, except per-share amounts, and shares in thousands) 2Q19 3Q19 4Q19 1Q20 (a) 2Q20 Operating income$ 76.4 $ 69.2 $ 78.6 $ 84.3 $ 79.4 Weighted average shares outstanding for basic earnings per share 158,816 154,257 150,138 145,829 143,422 Effect of dilutive securities on weighted average shares: Stock options, restricted stock and performance units 919 1,003 1,269 - 519 Weighted average shares outstanding for diluted earnings per share 159,735 155,260 151,407 145,829 143,941 Net operating income per diluted share$ 0.48 $ 0.45 $ 0.52 $ 0.58 $ 0.55 (a) Equivalent common shares of 768 were not included in the diluted weighted average shares outstanding due to the net less recognized in 1Q20. CNO Financial Group | Investor Overview | September 2020 36


 
Information Related to Certain Non-GAAP Financial Measures Debt to capital ratio, excluding accumulated other comprehensive income (loss) The debt to capital ratio, excluding accumulated other comprehensive income (loss), differs from the debt to capital ratio because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP financial measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. A reconciliation of these ratios is as follows: (dollars in millions) 4Q18 4Q19 1Q20 2Q20 Corporate notes payable$ 916.8 $ 989.1 $ 989.4 $ 989.7 Total shareholders' equity 3,370.9 4,677.0 3,765.8 4,731.2 Total capital$ 4,287.7 $ 5,666.1 $ 4,755.2 $ 5,720.9 Corporate debt to capital 21.4% 17.5% 20.8% 17.3% Corporate notes payable$ 916.8 $ 989.1 $ 989.4 $ 989.7 Total shareholders' equity 3,370.9 4,677.0 3,765.8 4,731.2 Less accumulated other comprehensive income (177.7) (1,372.5) (595.2) (1,520.2) Total capital$ 4,110.0 $ 4,293.6 $ 4,160.0 $ 4,200.7 Debt to total capital ratio, excluding AOCI (a non-GAAP financial measure) 22.3% 23.0% 23.8% 23.6% CNO Financial Group | Investor Overview | September 2020 37


 
v3.20.2
Cover Page
Sep. 17, 2020
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Sep. 17, 2020
Entity Registrant Name CNO Financial Group, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-31792
Entity Tax Identification Number 75-3108137
Entity Address, Address Line One 11825 North Pennsylvania Street
Entity Address, City or Town Carmel
Entity Address, State or Province IN
Entity Address, Postal Zip Code 46032
City Area Code 317
Local Phone Number 817-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001224608
Amendment Flag false
Common Stock, par value $0.01 per share  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol CNO
Security Exchange Name NYSE
Rights to purchase Series D Junior Participating Preferred Stock  
Document Information [Line Items]  
Title of 12(b) Security Rights to purchase Series D Junior Participating Preferred Stock
No Trading Symbol Flag true
Security Exchange Name NYSE